Garry Nolan - 02 Dec 2022 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Director
Signature
/s/ Garry Nolan, by Brian McKelligon, as Attorney-in-Fact
Issuer symbol
AKYA
Transactions as of
02 Dec 2022
Net transactions value
-$14,575
Form type
4
Filing time
06 Dec 2022, 17:29:45 UTC
Previous filing
02 Dec 2022
Next filing
27 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Sale $14,575 -1,100 -0.19% $13.25 591,978 02 Dec 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.